×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EVMN – evommune, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EVMN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/10
10:23 am
evmn
Evommune (EVMN) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $48.00 price target on the stock.
Medium
Report
Evommune (EVMN) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $48.00 price target on the stock.
4/7
10:11 am
evmn
Evommune (EVMN) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $50.00 price target on the stock.
Neutral
Report
Evommune (EVMN) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $50.00 price target on the stock.
4/6
01:38 pm
evmn
Evommune to Host KOL Webinar on April 13, 2026 Highlighting the Potential of MRGPRX2 Inhibition in Migraine [Yahoo! Finance]
Low
Report
Evommune to Host KOL Webinar on April 13, 2026 Highlighting the Potential of MRGPRX2 Inhibition in Migraine [Yahoo! Finance]
4/6
09:00 am
evmn
Evommune to Host KOL Webinar on April 13, 2026 Highlighting the Potential of MRGPRX2 Inhibition in Migraine
Medium
Report
Evommune to Host KOL Webinar on April 13, 2026 Highlighting the Potential of MRGPRX2 Inhibition in Migraine
3/20
08:07 am
evmn
Evommune (EVMN) was upgraded by Clear Str Llc to "strong-buy".
Medium
Report
Evommune (EVMN) was upgraded by Clear Str Llc to "strong-buy".
3/18
08:03 am
evmn
Evommune (EVMN) had its price target lowered by HC Wainwright from $65.00 to $50.00. They now have a "buy" rating on the stock.
Medium
Report
Evommune (EVMN) had its price target lowered by HC Wainwright from $65.00 to $50.00. They now have a "buy" rating on the stock.
3/17
06:52 am
evmn
Evommune (EVMN) was upgraded by Royal Bank Of Canada to "moderate buy".
Medium
Report
Evommune (EVMN) was upgraded by Royal Bank Of Canada to "moderate buy".
3/5
06:06 pm
evmn
Evommune, Inc. GAAP EPS of -$11.22, revenue of $13M [Seeking Alpha]
Medium
Report
Evommune, Inc. GAAP EPS of -$11.22, revenue of $13M [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/17
05:25 pm
evmn
Form 4 Evommune, Inc. For: Apr 16 Filed by: Patel Jeegar Pravinkumar
Neutral
Report
Form 4 Evommune, Inc. For: Apr 16 Filed by: Patel Jeegar Pravinkumar
4/17
05:24 pm
evmn
Form 4 Evommune, Inc. For: Apr 16 Filed by: Bauer Eugene
Neutral
Report
Form 4 Evommune, Inc. For: Apr 16 Filed by: Bauer Eugene
4/17
05:24 pm
evmn
Form 4 Evommune, Inc. For: Apr 16 Filed by: Carver Kyle
Neutral
Report
Form 4 Evommune, Inc. For: Apr 16 Filed by: Carver Kyle
4/17
05:24 pm
evmn
Form 4 Evommune, Inc. For: Apr 16 Filed by: Drew Janice Suzann
Neutral
Report
Form 4 Evommune, Inc. For: Apr 16 Filed by: Drew Janice Suzann
4/17
05:23 pm
evmn
Form 4 Evommune, Inc. For: Apr 16 Filed by: Moss Gregory S.
Neutral
Report
Form 4 Evommune, Inc. For: Apr 16 Filed by: Moss Gregory S.
4/17
05:23 pm
evmn
Form 4 Evommune, Inc. For: Apr 16 Filed by: Pena Luis C.
Neutral
Report
Form 4 Evommune, Inc. For: Apr 16 Filed by: Pena Luis C.
4/13
04:09 pm
evmn
Form 8-K Evommune, Inc. For: Apr 13
Low
Report
Form 8-K Evommune, Inc. For: Apr 13
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: